Drug Use Investigation of YAZ

Trial Profile

Drug Use Investigation of YAZ

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 08 Aug 2017

At a glance

  • Drugs Drospirenone/ethinylestradiol (Primary)
  • Indications Dysmenorrhoea
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms YAZ-DUI
  • Sponsors Bayer
  • Most Recent Events

    • 03 Aug 2017 Planned End Date changed from 15 May 2017 to 22 Jul 2018.
    • 03 Aug 2017 Planned primary completion date changed from 15 May 2017 to 30 Aug 2017.
    • 13 Nov 2015 Planned End Date changed from 1 Jul 2018 to 1 May 2017 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top